Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed1
Other1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT03019809Phase 2Unknown
A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients
Graft FailureHematopoietic Stem Cell TransplantationWiskott-Aldrich Syndrome
StudychairStart date: 2016-06-01
NCT02327351Phase 2/3Completed
TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID
Hematopoietic Stem Cell TransplantationPrimary Immune Deficiency Disorder
StudychairStart date: 2012-07-01

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dmitry Balashov

Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology

Moderately Similar
1 trials

Shared therapeutic areas:

Graft FailureHematopoietic Stem Cell TransplantationWiskott-Aldrich Syndrome

Worked with same sponsors:

Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Collaborated on 1 trial
Similarity Score34%

Dmitry Balashov, MD, PhD

Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology

Related
1 trials

Shared therapeutic areas:

Hematopoietic Stem Cell TransplantationPrimary Immunodeficiency Diseases

Worked with same sponsors:

Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Collaborated on 1 trial
Similarity Score24%

Qifa Liu, MD

Nanfang Hospital, Southern Medical University

Related
9 trials

Shared therapeutic areas:

Hematopoietic Stem Cell TransplantationGraft Failure
Similarity Score15%

liyan Miao, PhD

The First Affiliated Hospital of Soochow University

Related
4 trials

Shared therapeutic areas:

Hematopoietic Stem Cell Transplantation
Similarity Score8%

Meral Boşnak Güçlü, PhD

Gazi University

Related
10 trials

Shared therapeutic areas:

Hematopoietic Stem Cell Transplantation
Similarity Score8%

Jennifer Knight, MD

Medical College of Wisconsin

Related
4 trials

Shared therapeutic areas:

Hematopoietic Stem Cell Transplantation
Similarity Score8%

Ashok Srinivasan, MD

St. Jude Children's Research Hospital

Related
5 trials

Shared therapeutic areas:

Hematopoietic Stem Cell Transplantation
Similarity Score8%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Hematopoietic Stem Cell Transplantation
Similarity Score8%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Primary Immunodeficiency Diseases
Similarity Score8%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Primary Immunodeficiency Diseases
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03019809Phase 2StudyChair

A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Graft FailureHematopoietic Stem Cell TransplantationWiskott-Aldrich Syndrome
Unknown
NCT02327351Phase 2/3StudyChair

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Hematopoietic Stem Cell TransplantationPrimary Immune Deficiency Disorder
Completed

All 2 trials loaded